CN110368424A - A kind of Chinese medicine composition and preparation method thereof - Google Patents
A kind of Chinese medicine composition and preparation method thereof Download PDFInfo
- Publication number
- CN110368424A CN110368424A CN201910826042.3A CN201910826042A CN110368424A CN 110368424 A CN110368424 A CN 110368424A CN 201910826042 A CN201910826042 A CN 201910826042A CN 110368424 A CN110368424 A CN 110368424A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- rhizoma
- medicine composition
- wine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
The invention discloses a kind of Chinese medicine compositions and preparation method thereof, the Chinese medicine composition includes the component of following quality: rhizoma atractylodis 28-32g, root of Chinese clematis 28-32g, radix paeoniae rubra 18-20g, umbellate pore furgus 14-17g, scouring rush 14-17g, Herba Epimedii 20-23g, peach kernel 8-11g, motherwort 8-11g, Rhizoma Et Radix Notopterygii 13-15g, Rhizoma Chuanxiong 14-15g, Radix Angelicae Sinensis 9-12g, Radix Glycyrrhizae 9-12g, Radix Astragali 9-12g, has fabulous therapeutic effect for illnesss such as protrusion of lumber intervertebral disc, lumbar intervertebral disc bulge, cervical spondylosis, periostitis, Senile osteoarthritis.
Description
Technical field
The invention belongs to the field of Chinese medicines, more particularly, to a kind of Chinese medicine composition and preparation method thereof.
Background technique
Although the illness reason of bone and joint diseases is related with age, gender, obesity, heredity, environment, overexercise etc.,
It is the most fundamental the reason is that the abrasion of articular cartilage and the missing of knuckle synovia.The knuckle synovia not just lubrication between bone and bone
The main carriers of liquid or articular cartilage nutritional ingredient.And articular cartilage is covered on the bony surface of articular surface, it is very smooth and
It is flexible, huge load can be carried and absorb violent concussion, play a good protective effect to subchondral bone matter, make it
Damage impact, while friction when movement is reduced, it is the most important component part in joint.With advancing age, at
Year, the intracorporal ammonia sugared content of people gradually decreased, and one side will lead to knuckle synovia and lose source, aggravated hard between bone and bone
Property friction, the nutritional ingredient of articular cartilage can on the other hand supplied and goes wrong, keeps metabolism of articular cartilage abnormal so that
Articular cartilage is constantly degenerated and is worn, and softening occurs, erosion, falls off, directly contacts between subchondral bone exposure, bone and bone, sends out
Existing rigid friction, there are the symptoms such as pain, swelling, bony crepitus in joint, to cause synovitis, protrusion of lumber intervertebral disc, lumbar vertebrae
The illnesss such as disk bulging, Senile osteoarthritis.And there is presently no particularly effective treatment protrusion of lumber intervertebral disc, cervical spondylosis,
The method of the illnesss such as malum senile, although at present clinically there are many Chinese medicine composition for treating all kinds of bone and joint diseases,
But effect is all not satisfactory, and along with some toxic side effects.
Summary of the invention
It is an object of the invention to: a kind of Chinese medicine composition and preparation method thereof is provided, which can be to lumbar vertebrae
Disk bulging, protrusion of lumber intervertebral disc, cervical spondylosis, synovitis and Senile osteoarthritis are effectively treated.
The technical solution adopted by the invention is as follows:
A kind of Chinese medicine composition, the component including following quality: rhizoma atractylodis 28-32g, root of Chinese clematis 28-32g, radix paeoniae rubra 18-20g,
Umbellate pore furgus 14-17g, scouring rush 14-17g, Herba Epimedii 20-23g, peach kernel 8-11g, motherwort 8-11g, Rhizoma Et Radix Notopterygii 13-15g, Rhizoma Chuanxiong 14-
15g, Radix Angelicae Sinensis 9-12g, Radix Glycyrrhizae 9-12g, Radix Astragali 9-12g.
Further, which includes the component of following quality: rhizoma atractylodis 30g, root of Chinese clematis 30g, radix paeoniae rubra 20g,
Umbellate pore furgus 15g, scouring rush 15g, Herba Epimedii 20g, peach kernel 10g, motherwort 10g, Rhizoma Et Radix Notopterygii 15g, Rhizoma Chuanxiong 15g, Radix Angelicae Sinensis 10g, Radix Glycyrrhizae 10g,
Radix Astragali 10g.
The preparation method of above-mentioned Chinese medicine composition, includes the following steps:
(1) each component is weighed according to formula, and said components is ground into medicinal powder;
(2) medicinal powder obtained in step (1) is uniformly mixed, addition wine is tuned into paste and is applied with.
The wine being added in above-mentioned steps (2) is yellow rice wine or white wine.
The main component of wine is ethyl alcohol, and ethyl alcohol can dissolve more organic matter, is being carried out using wine to herb powder
When modulation is applied with, wine facilitates effective component in traditional Chinese medicinal components and dissolves out, and promotes the effect promoting blood circulation and removing obstruction in channels of traditional Chinese medicinal components, modulates with wine
Afterwards rhizoma atractylodis, the root of Chinese clematis, Rhizoma Et Radix Notopterygii channels-freeing dampness-dispelling act on enhancing, radix paeoniae rubra, umbellate pore furgus, Herba Epimedii, peach kernel, motherwort, Rhizoma Chuanxiong, Radix Angelicae Sinensis
Activating microcirculation and removing stasis medicinal capability improving so that the Chinese medicine preparation curative effect of the application is more significant, while can also remove drug after wine system
Toxic side effect, so that drug use is safer.
In conclusion by adopting the above-described technical solution, the beneficial effects of the present invention are:
It is monarch drug in a prescription that Chinese medicine composition provided by the invention, which selects rhizoma atractylodis, the root of Chinese clematis, radix paeoniae rubra, with channels-freeing dampness-dispelling, activating microcirculation and removing stasis medicinal,
Be aided with umbellate pore furgus again, scouring rush, Herba Epimedii, peach kernel, motherwort, Rhizoma Et Radix Notopterygii, rhizome of chuanxiong, Radix Angelicae Sinensis further strengthen the effect of activating microcirculation and removing stasis medicinal, together
When with Radix Glycyrrhizae, Radix Astragali homoiothermy tonifying Qi, promote the regeneration self-healing ability of body, promote the reparative regeneration of articular cartilage, to reach
The effect for treating lumbar intervertebral disc bulge, protrusion of lumber intervertebral disc, cervical spondylosis, synovitis and Senile osteoarthritis;And radix paeoniae rubra with
The drugs such as Rhizoma Chuanxiong, Radix Angelicae Sinensis can enhance whole activating microcirculation and removing stasis medicinal ability with using, and the thorn to articular cartilage is further enhanced when being applied with
Swash effect, promote the Regeneration and Repair of articular cartilage, enhances therapeutic effect;In addition, Chinese medicine composition of the invention is carried out using wine
Modulation, can further excite drug effect, eliminate the toxic side effect of medicinal material, so that patient is using safer.
Specific embodiment
In order to make the objectives, technical solutions, and advantages of the present invention clearer, with reference to embodiments, to the present invention
It is further elaborated.It should be appreciated that described herein, specific examples are only used to explain the present invention, is not used to limit
The fixed present invention, i.e., described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.
Therefore, the range of claimed invention is not intended to limit to the detailed description of the embodiment of invention below,
But it is merely representative of selected embodiment of the invention.Based on the embodiment of the present invention, those skilled in the art are not making wound
Every other embodiment obtained under the premise of the property made is worked, shall fall within the protection scope of the present invention.
It should be noted that the relational terms of term " first " and " second " or the like be used merely to an entity or
Operation is distinguished with another entity or operation, and without necessarily requiring or implying between these entities or operation, there are any
This actual relationship or sequence.Moreover, the terms "include", "comprise" or its any other variant be intended to it is non-exclusive
Property include so that include a series of elements process, method, article or equipment not only include those elements, but also
Further include other elements that are not explicitly listed, or further include for this process, method, article or equipment it is intrinsic
Element.In the absence of more restrictions, the element limited by sentence "including a ...", it is not excluded that including described
There is also other identical elements in the process, method, article or equipment of element.
Feature and performance of the invention are described in further detail with reference to embodiments.
Embodiment 1
The present embodiment provides a kind of Chinese medicine compositions, including rhizoma atractylodis 28g, root of Chinese clematis 32g, radix paeoniae rubra 18g, umbellate pore furgus 14g, scouring rush
14g, Herba Epimedii 20g, peach kernel 8g, motherwort 8g, Rhizoma Et Radix Notopterygii 14g, Rhizoma Chuanxiong 14g, Radix Angelicae Sinensis 12g, Radix Glycyrrhizae 12g, Radix Astragali 12g.
Preparation method:
(1) each component is weighed according to the quality in above-mentioned formula, and said components is ground into medicinal powder;
(2) medicinal powder obtained in step (1) is uniformly mixed, white wine is added and is tuned into paste, can be applied with.
Embodiment 2
The present embodiment provides a kind of Chinese medicine compositions, including rhizoma atractylodis 32g, root of Chinese clematis 28g, radix paeoniae rubra 20g, umbellate pore furgus 16g, scouring rush
17g, Herba Epimedii 23g, peach kernel 11g, motherwort 11g, Rhizoma Et Radix Notopterygii 13g, Rhizoma Chuanxiong 15g, Radix Angelicae Sinensis 9g, Radix Glycyrrhizae 9g, Radix Astragali 9g.
Preparation method:
(1) each component is weighed according to the quality in above-mentioned formula, and said components is ground into medicinal powder;
(2) medicinal powder obtained in step (1) is uniformly mixed, white wine is added and is tuned into paste, can be applied with.
Embodiment 3
This implementation provides a kind of Chinese medicine composition, rhizoma atractylodis 30g, root of Chinese clematis 30g, radix paeoniae rubra 20g, umbellate pore furgus 15g, scouring rush 15g, excessive
Sheep leaves of pulse plants 20g, peach kernel 10g, motherwort 10g, Rhizoma Et Radix Notopterygii 15g, Rhizoma Chuanxiong 15g, Radix Angelicae Sinensis 10g, Radix Glycyrrhizae 10g, Radix Astragali 10g.
Preparation method:
(1) each component is weighed according to the quality in above-mentioned formula, and said components is ground into medicinal powder;
(2) medicinal powder obtained in step (1) is uniformly mixed, yellow rice wine is added and is tuned into paste, can be applied with.
Experimental example
218 patients are randomly selected, wherein the patient of protrusion of lumber intervertebral disc 50, the patient of lumbar intervertebral disc bulge 26,
Cervical spondylosis patient 70, periostitis patient 42, Senile osteoarthritis patient 30, with Chinese medicine of the invention during treatment
Composition is applied with patient, changes a medicine sooner or later, and 7 days as a course for the treatment of, detection case after 8 courses for the treatment of, and treats to it
Effect is recorded, and specific data are as shown in table 1 below:
1 therapeutic effect record sheet of table
Grouping | It cures | It is effective | Effectively | In vain | Side effect | Total effective rate (%) |
Protrusion of lumber intervertebral disc | 29 | 15 | 2 | 4 | Nothing | 92 |
Lumbar intervertebral disc bulge | 15 | 6 | 3 | 2 | Nothing | 92.3 |
Cervical spondylosis | 43 | 18 | 4 | 5 | Nothing | 92.9 |
Periostitis | 23 | 11 | 5 | 3 | Nothing | 92.9 |
Senile osteoarthritis | 13 | 6 | 6 | 5 | Nothing | 83.3 |
As can be seen from Table 1, Chinese medicine composition provided by the invention for protrusion of lumber intervertebral disc, lumbar intervertebral disc bulge,
When cervical spondylosis, periostitis are treated, total effective rate can reach 92% or more, be treated for Senile osteoarthritis
When, effective percentage can reach 83.3%, all have preferable curative effect for above-mentioned illness, and do not generate malicious pair when being treated
Effect, will not damage patient.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all in essence of the invention
Made any modifications, equivalent replacements, and improvements etc., should all be included in the protection scope of the present invention within mind and principle.
Claims (4)
1. a kind of Chinese medicine composition, which is characterized in that the component including following quality: rhizoma atractylodis 28-32g, root of Chinese clematis 28-32g, red
Chinese herbaceous peony 18-20g, umbellate pore furgus 14-17g, scouring rush 14-17g, Herba Epimedii 20-23g, peach kernel 8-11g, motherwort 8-11g, Rhizoma Et Radix Notopterygii 13-15g,
Rhizoma Chuanxiong 14-15g, Radix Angelicae Sinensis 9-12g, Radix Glycyrrhizae 9-12g, Radix Astragali 9-12g.
2. Chinese medicine composition according to claim 1, which is characterized in that the component including following quality: rhizoma atractylodis 30g, prestige
Medicine xiaolingxian 30g, radix paeoniae rubra 20g, umbellate pore furgus 15g, scouring rush 15g, Herba Epimedii 20g, peach kernel 10g, motherwort 10g, Rhizoma Et Radix Notopterygii 15g, Rhizoma Chuanxiong 15g,
Radix Angelicae Sinensis 10g, Radix Glycyrrhizae 10g, Radix Astragali 10g.
3. a kind of preparation method of Chinese medicine composition described in claim 1, which comprises the steps of:
(1) each component is weighed according to formula, and said components is ground into medicinal powder;
(2) medicinal powder obtained in step (1) is uniformly mixed, addition wine is tuned into paste and is applied with.
4. the preparation method of Chinese medicine composition according to claim 3, which is characterized in that be added in the step (2)
Wine is yellow rice wine or white wine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910826042.3A CN110368424A (en) | 2019-09-03 | 2019-09-03 | A kind of Chinese medicine composition and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910826042.3A CN110368424A (en) | 2019-09-03 | 2019-09-03 | A kind of Chinese medicine composition and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110368424A true CN110368424A (en) | 2019-10-25 |
Family
ID=68261377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910826042.3A Pending CN110368424A (en) | 2019-09-03 | 2019-09-03 | A kind of Chinese medicine composition and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110368424A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1485063A (en) * | 2002-09-26 | 2004-03-31 | 纪文华 | Chinese traditional medicine formulation for rheumatism and its orthopaedic disease |
CN101411802A (en) * | 2008-11-21 | 2009-04-22 | 赵献民 | Black plaster for treating hyperosteogeny and preparation method thereof |
CN107583026A (en) * | 2017-10-31 | 2018-01-16 | 南宁市共健源健康科技有限公司 | A kind of Chinese medicine composition for spinal lesion and preparation method thereof |
-
2019
- 2019-09-03 CN CN201910826042.3A patent/CN110368424A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1485063A (en) * | 2002-09-26 | 2004-03-31 | 纪文华 | Chinese traditional medicine formulation for rheumatism and its orthopaedic disease |
CN101411802A (en) * | 2008-11-21 | 2009-04-22 | 赵献民 | Black plaster for treating hyperosteogeny and preparation method thereof |
CN107583026A (en) * | 2017-10-31 | 2018-01-16 | 南宁市共健源健康科技有限公司 | A kind of Chinese medicine composition for spinal lesion and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103585299B (en) | Medicine for treating disc protrusion and bulge of lumbar vertebra and cervical vertebra | |
CN1099983A (en) | Medicine for treating rheumatoid or rheumatic arthritis and hyperosteogeny, and method for preparing same | |
CN105664092A (en) | Bone disease treating Hui-nationality medicinal liquor for external use | |
CN103784811B (en) | A kind of Chinese herbal medicine treating nyctalopia and preparation method thereof | |
CN103784890A (en) | Traditional Chinese medicine composition for treating bone diseases | |
CN110368424A (en) | A kind of Chinese medicine composition and preparation method thereof | |
CN106177002A (en) | A kind of medicated powder medicated wine complex treating bone matrix hyperplasia | |
CN104258299A (en) | Traditional Chinese medicine for treating mumps | |
CN111166854A (en) | Chinese patent medicine for relieving pain of cancer patient | |
CN104116831A (en) | Swelling decreasing and pain relieving particle | |
CN107823633A (en) | A kind of pharmaceutical composition for treating arthralgia | |
CN103989767B (en) | A kind of treat verruca plana pharmaceutical composition and preparation technology and application | |
CN115944680B (en) | Traditional Chinese medicine detumescence emplastrum for treating orthopedics postoperative red swelling and ecchymosis and preparation method thereof | |
CN107281443A (en) | A kind of pharmaceutical composition of cold dispelling promoting blood circulation and stopping pain and its production and use | |
Zhang et al. | Exploring dosage patterns of Chinese herbal medicine for recurrent headaches: A data mining analysis. | |
CN105233158A (en) | Traditional Chinese medicinal composition for treating cervical spondylosis and preparation method of traditional Chinese medicinal composition | |
CN104435229A (en) | Traditional Chinese medicine agent for treating cervical spondylosis and preparation method thereof | |
CN107029155A (en) | A kind of medicine for being used to treat cervical spondylopathy | |
CN102166333B (en) | Chinese medicine composition for treating caput femoris necrosis | |
CN115887590A (en) | Mongolian medicine medicated bath composition for treating psoriasis as well as preparation method and application thereof | |
CN114762719A (en) | Traditional Chinese medicine composition for relaxing tendons and activating collaterals and preparation method thereof | |
CN109091579A (en) | A kind of Recipe of plaster for treating cervical spondylosis | |
CN110638975A (en) | Medicine formula for treating pain | |
CN107184808A (en) | A kind of Chinese medicine composition for treating asthma and its application | |
CN115671233A (en) | Traditional Chinese medicine composition, preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191025 |